<DOC>
	<DOCNO>NCT00706017</DOCNO>
	<brief_summary>This observational study conduct North America . The aim observational study evaluate incidence adverse event use Levemir速 normal clinical practice condition .</brief_summary>
	<brief_title>Observational Study Evaluate Safety Levemir速 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Detemir</mesh_term>
	<criteria>Type 1 2 diabetes Including newly diagnose insulin insulin analogue treatment Selection discretion physician Adult patient type 1 2 diabetes mellitus , type 1 patient 6 year old Current treatment Levemir速 Previously enrol study Hypersensitivity Levemir速</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>